Live tape
Top 8, mentions 7d7,457NKE2,080 mentions▲ +0.03GOOGL1,542 mentions▲ +0.03NVDA798 mentions▲ +0.09META765 mentions▲ +0.05TSLA640 mentions▲ +0.06QQQ627 mentions▲ +0.09SPCX518 mentions▲ +0.08MU487 mentions▲ +0.08

Equity · Healthcare

ICLR

NASDAQ

ICON Public Limited Company

$165 +2.48% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Aug 7, 2026
Price · Chart
Our own end-of-day closes 24 sessions
$190 $150 7 Jul 7 Aug

The line runs $169 on 7 July through $165 on 7 August, on a scale from $150 to $190. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

TradingView chart · our licensed closes: 24 sessions, 7 Jul – 7 Aug 2026

52-week range $80 – $203
Avg volume 320.6K

as of Aug 7, 2026

ICLR insider trades

SEC Form 4 · last 90 days · newest reported trade 17 Sep 2026
Open-market buys 0
Open-market sells 12
Net sold $4.04M
Non-trade filings 12
Date Insider Type Shares Value
17 Sep 2026 Murphy Ronan Martin Director Sell 5,005 $876K
17 Sep 2026 McCague Eugene Pacelli Director Sell 3,255 $570K
16 Sep 2026 CLIMAX JOHN DR Director Sell 5,005 $876K
11 Aug 2026 CLIMAX JOHN DR Director Sell 841 $138K
11 Aug 2026 Clerkin Nigel Bernard John Chief Financial Officer Sell 2,267 $372K
11 Aug 2026 Grais Linda Director Sell 841 $138K
11 Aug 2026 McCague Eugene Pacelli Director Sell 841 $138K
11 Aug 2026 Murphy Ronan Martin Director Sell 841 $138K
11 Aug 2026 Murray Ciaran Director Sell 2,677 $440K
11 Aug 2026 O'Neill Julie Director Sell 915 $150K
11 Aug 2026 Whitaker Anne Clem Director Sell 841 $138K
10 Aug 2026 Balfe Barry Edward Chief Executive Officer Sell 382 $63K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
17 Sep 2026 Murphy Ronan Martin Director Option exercise 5,005 $629K
17 Sep 2026 McCague Eugene Pacelli Director Option exercise 3,255 $409K
16 Sep 2026 CLIMAX JOHN DR Director Option exercise 5,005 $629K
10 Aug 2026 CLIMAX JOHN DR Director Option exercise 1,732
10 Aug 2026 Clerkin Nigel Bernard John Chief Financial Officer Option exercise 4,293
10 Aug 2026 Grais Linda Director Option exercise 1,732
10 Aug 2026 McCague Eugene Pacelli Director Option exercise 1,732
10 Aug 2026 Murphy Ronan Martin Director Option exercise 1,732
10 Aug 2026 Murray Ciaran Director Option exercise 2,677
10 Aug 2026 O'Neill Julie Director Option exercise 1,732
10 Aug 2026 Whitaker Anne Clem Director Option exercise 1,732
07 Aug 2026 Balfe Barry Edward Chief Executive Officer Option exercise 728

ICLR reported financials

SEC EDGAR XBRL SEC EDGAR

ICLR reported revenue of $8.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was $229.3M.

Figure Reported Period
Revenue $8.3B 31 Dec 2025 fiscal year
Net income $229.3M 31 Dec 2025 fiscal year
Diluted EPS $2.90 31 Dec 2025 fiscal year
Total assets $16.3B 31 Dec 2025 at period end
Total equity $9.2B 31 Dec 2025 at period end

ICLR institutional holders

SEC Form 13F SEC EDGAR

8 of the 45 institutional funds we track reported a ICLR position for the quarter ended 30 Jun 2026 — a combined $370.2M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
D. E. Shaw & Co. Held (±25%) +13.2% shares 1,357,143 $235.7M
Point72 Asset Management Added +3,610.3% shares 365,945 $63.6M
Marshall Wace Added +1,121.1% shares 175,440 $30.5M
Citadel Advisors Trimmed −41.0% shares 148,573 $25.8M
Millennium Management Held (±25%) −4.5% shares 48,483 $8.4M
Tudor Investment Corp Trimmed −59.8% shares 26,270 $4.6M
Balyasny Asset Management Trimmed −96.4% shares 4,859 $844K
Renaissance Technologies New position 4,500 $782K
Maverick Capital Exited
Two Sigma Investments Exited

ICLR fails-to-deliver

SEC CNS data SEC

On 11 Sep 2026, 709 shares of ICLR failed to deliver (about $117K).

Settlement date Shares failed Notional % of shares out
11 Sep 2026 709 $117K 0.001%
04 Sep 2026 17 $3K <0.001%
02 Sep 2026 756 $122K 0.001%
01 Sep 2026 17 $3K <0.001%
31 Aug 2026 151 $26K <0.001%
27 Aug 2026 75 $13K <0.001%
26 Aug 2026 7,659 $1.3M 0.010%
25 Aug 2026 36 $6K <0.001%

Congressional trades in ICLR

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in ICLR is a sale by Kevin Hern (house, OK), dated 14 Aug 2026.

Date Member Type Amount
14 Aug 2026 filed 01 Sep 2026 Kevin Hern house · Republican–OK Sale $15K–$50K
04 Sep 2024 filed 06 Sep 2024 John James house · Republican–MI Sale $1K–$15K
12 Jun 2024 filed 02 Sep 2024 John James house · Republican–MI Purchase $1K–$15K
31 Jan 2023 filed 14 Feb 2023 Kevin Hern house · Republican–OK Sale $1K–$15K
27 Jul 2020 filed 15 Aug 2020 Kevin Hern house · Republican–OK Purchase $1K–$15K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 31 Dec 2025
  3. SEC EDGARSEC EDGAR 13F filings
  4. SECSEC fails-to-deliver (CNS) data
  5. House disclosuresU.S. House of Representatives financial disclosures
  6. TradingViewthe price chart widget, drawn by TradingView from their own data